Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CUTERA INCCUTR · Entity 82936 | Director | June 14, 2018 | June 15, 2018 |
| ICU MEDICAL INC/DEICUI · Entity 2385 | Director | August 11, 2026 | August 11, 2026 |
| IROBOT CORPIRBT · Entity 71819 | Director | June 11, 2021 | June 15, 2021 |
| METTLER TOLEDO INTERNATIONAL INC/MTD · Entity 3168 | Director | November 10, 2025 | November 13, 2025 |
| VARIAN MEDICAL SYSTEMS INCVAR · Entity 140252 | Exec VP and CFO | February 15, 2017 | February 16, 2017 |
| Varex Imaging CorpVREX · Entity 5135 | Director | January 19, 2017 | January 20, 2017 |
| Viatris IncVTRS · Entity 3277 | Director | March 06, 2026 | March 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CUTERA INC
Report date June 14, 2018 · Filed June 15, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| COMMONSEC Table I · non-derivative | Direct | 8,048 |
Reported balance
After 2018-06-14 transaction · row 1
1 source rowRow 1 · 2018-06-14 · Grant · Acquired 2,232 · Balance 8,048 F1: Grant of Restricted Stock Units (RSUs) that will entitle the Reporting Person to receive one share of Common Stock per one RSU. The RSUs vest upon the conclusion of the Cutera, Inc. 2019 Annual General Meeting of Stockholders expected to occur on or about June 14, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of Restricted Stock Units (RSUs) that will entitle the Reporting Person to receive one share of Common Stock per one RSU. The RSUs vest upon the conclusion of the Cutera, Inc. 2019 Annual General Meeting of Stockholders expected to occur on or about June 14, 2019.
ICU MEDICAL INC/DE
Report date August 11, 2026 · Filed August 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,871 |
Reported balance
After 2026-08-11 transaction · row 1
1 source rowRow 1 · 2026-08-11 · Sale · Disposed 378 · Balance 4,871 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $182.4808 to $182.5701, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $182.4808 to $182.5701, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
IROBOT CORP
Report date June 11, 2021 · Filed June 15, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,555 |
Reported balance
After 2021-06-11 transaction · row 1
1 source rowRow 1 · 2021-06-11 · Grant · Acquired 1,826 · Balance 8,555 F1: Consists of a restricted stock unit award made pursuant to the iRobot Corporation 2018 Stock Option and Incentive Plan. The restricted stock units vest (100%) on the first anniversary of the grant date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in no event later than 30 days after such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of a restricted stock unit award made pursuant to the iRobot Corporation 2018 Stock Option and Incentive Plan. The restricted stock units vest (100%) on the first anniversary of the grant date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in no event later than 30 days after such vesting date.
METTLER TOLEDO INTERNATIONAL INC/
Report date November 10, 2025 · Filed November 13, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 374 |
Ending reported balance
After 2025-11-11 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2025-11-10 · Exercise / conversion · Acquired 474 · Balance 785 Row 2 · 2025-11-10 · Sale · Disposed 474 · Balance 311 Row 3 · 2025-11-11 · Grant · Acquired 63 · Balance 374 |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $595.31 · Expires 2028-11-08 | Direct | 0 |
Reported balance
After 2025-11-10 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-11-10 · Exercise / conversion · Disposed 474 · Balance 0 F1: The options vested annually in two equal installments beginning on the first anniversary of the date of grant. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1,445.06 · Expires 2035-11-11 | Direct | 162 |
Reported balance
After 2025-11-11 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2025-11-11 · Grant · Acquired 162 · Balance 162 F2: The options vest annually in two equal installments beginning on the first anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The options vested annually in two equal installments beginning on the first anniversary of the date of grant.
F2: The options vest annually in two equal installments beginning on the first anniversary of the date of grant.
VARIAN MEDICAL SYSTEMS INC
Report date February 15, 2017 · Filed February 16, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,260 |
Ending reported balance
After 2017-02-15 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2017-02-15 · Exercise / conversion · Acquired 2,401 · Balance 9,037 F1: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Row 2 · 2017-02-15 · Exercise / conversion · Acquired 2,033 · Balance 11,070 F1: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Row 3 · 2017-02-15 · Exercise / conversion · Acquired 1,192 · Balance 12,262 F1: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Row 4 · 2017-02-15 · Tax withholding · Disposed 2,002 · Balance 10,260 F2: Represents shares withheld from vested restricted stock units for the payment of federal, state and payroll taxes due on vesting. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 7,643 |
Reported balance
After 2017-02-15 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2017-02-15 · Exercise / conversion · Disposed 2,401 · Balance 7,643 F1: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F3: The restricted stock units vest in three equal installments on February 15, 2015, February 15, 2016, and February 15, 2017. Vested shares will be delivered to the reporting person on vest date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 5,610 |
Reported balance
After 2017-02-15 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2017-02-15 · Exercise / conversion · Disposed 2,033 · Balance 5,610 F1: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F4: The restricted stock units vest in three equal installments on February 15, 2016, February 15, 2017, and February 15, 2018. Vested shares will be delivered to the reporting person on vest date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 4,418 |
Reported balance
After 2017-02-15 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2017-02-15 · Exercise / conversion · Disposed 1,192 · Balance 4,418 F1: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F5: The restricted stock units vest in three equal installments on February 15, 2017, February 15, 2018, and February 15, 2019. Vested shares will be delivered to the reporting person on vest date. F6: Includes restricted stock units that were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Restricted stock units that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding to the nearest whole share. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 22,126 |
Reported balance
Holding disclosure · report date 2017-02-15 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 22,126 |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.
F2: Represents shares withheld from vested restricted stock units for the payment of federal, state and payroll taxes due on vesting.
F3: The restricted stock units vest in three equal installments on February 15, 2015, February 15, 2016, and February 15, 2017. Vested shares will be delivered to the reporting person on vest date.
F4: The restricted stock units vest in three equal installments on February 15, 2016, February 15, 2017, and February 15, 2018. Vested shares will be delivered to the reporting person on vest date.
F5: The restricted stock units vest in three equal installments on February 15, 2017, February 15, 2018, and February 15, 2019. Vested shares will be delivered to the reporting person on vest date.
F6: Includes restricted stock units that were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Restricted stock units that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding to the nearest whole share.
Varex Imaging Corp
Report date January 19, 2017 · Filed January 20, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| No securities are beneficially owned.SEC Table I · non-derivative | Direct | 0 |
Reported balance
Holding disclosure · report date 2017-01-19 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 0 |
Viatris Inc
Report date March 06, 2026 · Filed March 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 62,667 |
Ending reported balance
After 2026-03-06 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-03-06 · Exercise / conversion · Acquired 23,660 · Balance 61,492 Row 2 · 2026-03-06 · Exercise / conversion · Acquired 1,175 · Balance 62,667 F1: Fractional shares have been rounded up in connection with the settlement described in footnote 3 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-03-06 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-03-06 · Exercise / conversion · Disposed 23,660 · Balance 0 F2: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs vested in full on March 6, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 15,890 |
Reported balance
After 2026-03-06 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-03-06 · Grant · Acquired 15,890 · Balance 15,890 F4: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 6, 2027. |
| Dividend Equivalent UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-03-06 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-03-06 · Exercise / conversion · Disposed 1,174.4921 · Balance 0 F3: Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 6, 2025 and vested on the same schedule as the underlying RSUs. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. |
Filing footnotes · ownership attribution and instrument terms
F1: Fractional shares have been rounded up in connection with the settlement described in footnote 3 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan.
F2: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs vested in full on March 6, 2026.
F3: Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 6, 2025 and vested on the same schedule as the underlying RSUs. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11.
F4: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 6, 2027.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
NanoString Technologies Inc
Report date May 06, 2024 · Filed May 08, 2024
Section 16 reporting ended · disclosed 2024-05-08. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 62,579 |
Reported balance
After 2024-05-06 transaction · row 1
1 source rowRow 1 · 2024-05-06 · Exercise / conversion · Acquired 41,133 · Balance 62,579 F1: The shares have not been delivered to the reporting person. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2024-05-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-05-06 · Exercise / conversion · Disposed 41,133 · Balance 0 F2: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock. F3: Pursuant to the terms of the award, as a result of the closing of the sale of substantially all of the assets of the Company to Bruker Corporation, which constituted a Change of Control under the terms of the RSU award agreement, the vesting of the RSUs accelerated. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares have not been delivered to the reporting person.
F2: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock.
F3: Pursuant to the terms of the award, as a result of the closing of the sale of substantially all of the assets of the Company to Bruker Corporation, which constituted a Change of Control under the terms of the RSU award agreement, the vesting of the RSUs accelerated.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 18, 2019 Filed Jun 20, 2019 16:14 UTC | NanoString Technologies Inc NSTG · Entity 15988 | GrantRestricted Stock Units · Derivative | 1,890 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001401708-19-000155 · wf-form4_156106164308792.xml · derivative · entry 2 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,890 Underlying: Common Stock · 1,890 shares Expires not disclosed F2 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock. F3 · derivative.exercise_date: 100% of the RSUs vest on the earlier of the one-year anniversary of June 18, 2019 or the date immediately prior to the 2020 annual meeting of stockholders. F3 · derivative.expiration_date: 100% of the RSUs vest on the earlier of the one-year anniversary of June 18, 2019 or the date immediately prior to the 2020 annual meeting of stockholders. Read SEC document |
| June 18, 2019 Filed Jun 20, 2019 16:14 UTC | NanoString Technologies Inc NSTG · Entity 15988 | GrantStock Options (right to buy) · Derivative | 3,857 | $0.00 Strike: $26.45 | $0.00 |
DisclosureSEC source: 0001401708-19-000155 · wf-form4_156106164308792.xml · derivative · entry 1 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,857 Underlying: Common Stock · 3,857 shares Expires 2029-06-18 F1 · derivative.exercise_date: 100% of the shares subject to the Option vest on the earlier of the one-year anniversary of June 18, 2019 or the date immediately prior to the 2020 annual meeting of stockholders. Read SEC document |
| June 07, 2019 Filed Jun 11, 2019 18:16 UTC | IROBOT CORP IRBT · Entity 71819 | GrantCommon Stock | 1,910 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-036192 · doc4.xml · nonDerivative · entry 1 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,969 F1 · shares: Consists of a restricted stock unit award made pursuant to the iRobot Corporation 2018 Stock Option and Incentive Plan. The restricted stock units vest (100%) on the first anniversary of the grant date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in no event later than 30 days after such vesting date. Read SEC document |
| May 15, 2019 Filed May 16, 2019 16:46 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 1,253 | $0.00 Strike: $225.27 | $0.00 |
DisclosureSEC source: 0001209191-19-030253 · doc4.xml · derivative · entry 4 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,253 Underlying: Common Stock · 1,253 shares Expires 2029-05-15 Read SEC document |
| May 15, 2019 Filed May 16, 2019 16:46 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantCommon Stock · Derivative | 378 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-030253 · doc4.xml · derivative · entry 3 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 378 Underlying: Common Stock · 378 shares Expires 2020-05-15 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award. Read SEC document |
| May 15, 2019 Filed May 16, 2019 16:46 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 315 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-030253 · doc4.xml · derivative · entry 2 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 315 shares Expires 2019-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award. Read SEC document |
| May 15, 2019 Filed May 16, 2019 16:46 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 315 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-030253 · doc4.xml · nonDerivative · entry 1 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 25, 2019 Filed Mar 27, 2019 16:31 UTC | NanoString Technologies Inc NSTG · Entity 15988 | GrantCommon Stock · Derivative | 4,410 | $0.00 Strike: $23.34 | $0.00 |
DisclosureSEC source: 0001401708-19-000111 · wf-form4_155371869962980.xml · derivative · entry 1 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,410 Underlying: Common Stock · 4,410 shares Expires 2029-03-25 F1 · derivative.exercise_date: 100% of the shares subject to the Option vest on the the date prior to the day of the Company's 2019 annual meeting of stockholders. Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 15:25 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | GrantStock Option (right to buy) · Derivative | 474 | $0.00 Strike: $595.31 | $0.00 |
DisclosureSEC source: 0001515622-18-000042 · edgar.xml · derivative · entry 2 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 474 Underlying: Common stock, par value $0.01 per share · 474 shares Expires 2028-11-08 F1 · derivative.exercise_date: The options vest annually in two equal installments beginning on the first anniversary of the date of grant. Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 15:25 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | GrantCommon Stock, par value $0.01 per share | 76 | $0.00 | $0.00 |
DisclosureSEC source: 0001515622-18-000042 · edgar.xml · nonDerivative · entry 1 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93 Read SEC document |
| June 14, 2018 Filed Jun 15, 2018 17:33 UTC | CUTERA INC CUTR · Entity 82936 | GrantCOMMON | 2,232 | $44.80 | $99,993.60 |
DisclosureSEC source: 0001437749-18-011940 · rdgdoc.xml · nonDerivative · entry 1 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,048 F1 · shares: Grant of Restricted Stock Units (RSUs) that will entitle the Reporting Person to receive one share of Common Stock per one RSU. The RSUs vest upon the conclusion of the Cutera, Inc. 2019 Annual General Meeting of Stockholders expected to occur on or about June 14, 2019. Read SEC document |
| June 08, 2018 Filed Jun 12, 2018 19:37 UTC | IROBOT CORP IRBT · Entity 71819 | GrantCommon Stock | 1,868 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-037332 · doc4.xml · nonDerivative · entry 1 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,059 F1 · shares: Consists of a restricted stock unit award made pursuant to the iRobot Corporation 2018 Stock Option and Incentive Plan. The restricted stock units vest (100%) on the first anniversary of the grant date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in no event later than 30 days after such vesting date. Read SEC document |
| May 15, 2018 Filed May 17, 2018 21:10 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 1,163 | $0.00 Strike: $269.80 | $0.00 |
DisclosureSEC source: 0001209191-18-031036 · doc4.xml · derivative · entry 2 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,163 Underlying: Common Stock · 1,163 shares Expires 2028-05-15 Read SEC document |
| May 15, 2018 Filed May 17, 2018 21:10 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantCommon Stock · Derivative | 315 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-031036 · doc4.xml · derivative · entry 1 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315 Underlying: Common Stock · 315 shares Expires 2019-05-15 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award. Read SEC document |
| May 11, 2018 Filed May 11, 2018 16:23 UTC | CUTERA INC CUTR · Entity 82936 | PurchaseCOMMON | 2,000 | $35.60 | $71,200.00 |
DisclosureSEC source: 0001437749-18-009619 · rdgdoc.xml · nonDerivative · entry 1 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,816 F1 · shares: Represents open market purchase of non-derivative security. Read SEC document |
| May 09, 2018 Filed May 10, 2018 21:04 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 475 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-029306 · doc4.xml · derivative · entry 2 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 475 shares Expires 2018-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. Read SEC document |
| May 09, 2018 Filed May 10, 2018 21:04 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 475 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-029306 · doc4.xml · nonDerivative · entry 1 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,580 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. Read SEC document |
| January 01, 2018 Filed Jan 3, 2018 18:19 UTC | NanoString Technologies Inc NSTG · Entity 15988 | GrantCommon Stock · Derivative | 10,168 | $0.00 Strike: $7.47 | $0.00 |
DisclosureSEC source: 0001401708-18-000012 · wf-form4_151502155242054.xml · derivative · entry 1 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,168 Underlying: Common Stock · 10,168 shares Expires 2027-12-31 F1 · derivative.exercise_date: 100% of the shares subject to the Option vest on the one year anniversary of January 1, 2018. The vesting of shares subject to the Option will accelerate in full upon a "change in control" as defined in the 2013 Equity Incentive Plan. Read SEC document |
| November 02, 2017 Filed Nov 6, 2017 15:39 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | GrantStock Option (right to buy) · Derivative | 476 | $0.00 Strike: $671.60 | $0.00 |
DisclosureSEC source: 0001515622-17-000080 · edgar.xml · derivative · entry 2 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 476 Underlying: Common stock, par value $0.01 per share · 476 shares Expires 2027-11-02 F1 · derivative.exercise_date: The options vest annually in two equal installments beginning on the first anniversary of the date of grant. Read SEC document |
| November 02, 2017 Filed Nov 6, 2017 15:39 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | GrantCommon Stock, par value $0.01 per share | 17 | $0.00 | $0.00 |
DisclosureSEC source: 0001515622-17-000080 · edgar.xml · nonDerivative · entry 1 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17 Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 17:51 UTC | IROBOT CORP IRBT · Entity 71819 | GrantCommon Stock | 1,354 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-039624 · doc4.xml · nonDerivative · entry 1 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,191 F1 · shares: Consists of a restricted stock unit award made pursuant to the iRobot Corporation 2015 Stock Option and Incentive Plan. The restricted stock units vest (100%) on the first anniversary of the grant date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in no event later than 30 days after such vesting date Read SEC document |
| May 16, 2017 Filed May 17, 2017 01:23 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 743 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-032907 · doc4.xml · derivative · entry 2 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 743 shares Expires 2017-05-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. Read SEC document |
| May 16, 2017 Filed May 17, 2017 01:23 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 743 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-032907 · doc4.xml · nonDerivative · entry 1 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,105 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| May 09, 2017 Filed May 10, 2017 00:05 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantNon-Qualified Stock Options (right to buy) · Derivative | 1,765 | $158.20 Strike: $158.20 | $279,223.00 |
DisclosureSEC source: 0001209191-17-031098 · doc4.xml · derivative · entry 2 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,765 Underlying: Common Stock · 1,765 shares Expires 2027-05-09 Read SEC document |
| May 09, 2017 Filed May 10, 2017 00:05 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantCommon Stock · Derivative | 475 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-031098 · doc4.xml · derivative · entry 1 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 475 Underlying: Common Stock · 475 shares Expires 2018-05-09 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. Read SEC document |
| May 09, 2017 Filed May 11, 2017 13:09 UTC | NanoString Technologies Inc NSTG · Entity 15988 | GrantStock Option (right to buy) · Derivative | 17,353 | $0.00 Strike: $18.55 | $0.00 |
DisclosureSEC source: 0001209191-17-031473 · doc4.xml · derivative · entry 1 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,353 Underlying: Common Stock · 17,353 shares Expires 2027-05-08 F1 · derivative.exercise_date: 50% of the shares subject to the Option vest on the one-year anniversary of May 9, 2017 (the "Vesting Commencement Date") and thereafter the remaining 50% of the total shares vest in twelve equal monthly installments on each monthly anniversary of the Vesting Commencement Date, subject to continued service as a director through each vesting date. Read SEC document |
| March 10, 2017 Filed Mar 15, 2017 17:46 UTC | IROBOT CORP IRBT · Entity 71819 | GrantCommon Stock | 3,837 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-020873 · doc4.xml · nonDerivative · entry 1 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,837 F1 · shares: Consists of a restricted stock unit award made pursuant to the iRobot Corporation 2015 Stock Option and Incentive Plan. The restricted stock units vest over a four-year period, at a rate of twenty-five percent (25%) on each anniversary of the grant date. Vested shares will be delivered to the reporting person as soon as practicable following each vesting date, but in no event later than 30 days after each such vesting date. Read SEC document |
| February 15, 2017 Filed Feb 16, 2017 20:40 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionRestricted Stock Units · Derivative | 1,192 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-006735 · form4.xml · derivative · entry 8 FINNEY ELISHA W · CIK 0001217439 · Exec VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,418 Underlying: Common Stock · 1,192 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F5 · derivative.exercise_date: The restricted stock units vest in three equal installments on February 15, 2017, February 15, 2018, and February 15, 2019. Vested shares will be delivered to the reporting person on vest date. F5 · derivative.expiration_date: The restricted stock units vest in three equal installments on February 15, 2017, February 15, 2018, and February 15, 2019. Vested shares will be delivered to the reporting person on vest date. F6 · balance_after: Includes restricted stock units that were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Restricted stock units that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding to the nearest whole share. Read SEC document |
| February 15, 2017 Filed Feb 16, 2017 20:40 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionRestricted Stock Units · Derivative | 2,033 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-006735 · form4.xml · derivative · entry 7 FINNEY ELISHA W · CIK 0001217439 · Exec VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,610 Underlying: Common Stock · 2,033 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F4 · derivative.exercise_date: The restricted stock units vest in three equal installments on February 15, 2016, February 15, 2017, and February 15, 2018. Vested shares will be delivered to the reporting person on vest date. F4 · derivative.expiration_date: The restricted stock units vest in three equal installments on February 15, 2016, February 15, 2017, and February 15, 2018. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 15, 2017 Filed Feb 16, 2017 20:40 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionRestricted Stock Units · Derivative | 2,401 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-006735 · form4.xml · derivative · entry 6 FINNEY ELISHA W · CIK 0001217439 · Exec VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,643 Underlying: Common Stock · 2,401 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F3 · derivative.exercise_date: The restricted stock units vest in three equal installments on February 15, 2015, February 15, 2016, and February 15, 2017. Vested shares will be delivered to the reporting person on vest date. F3 · derivative.expiration_date: The restricted stock units vest in three equal installments on February 15, 2015, February 15, 2016, and February 15, 2017. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 15, 2017 Filed Feb 16, 2017 20:40 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Tax withholdingCommon Stock | 2,002 | $81.12 | $162,402.24 |
DisclosureSEC source: 0001127602-17-006735 · form4.xml · nonDerivative · entry 4 FINNEY ELISHA W · CIK 0001217439 · Exec VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,260 F2 · shares: Represents shares withheld from vested restricted stock units for the payment of federal, state and payroll taxes due on vesting. Read SEC document |
| February 15, 2017 Filed Feb 16, 2017 20:40 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,192 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-006735 · form4.xml · nonDerivative · entry 3 FINNEY ELISHA W · CIK 0001217439 · Exec VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,262 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Read SEC document |
| February 15, 2017 Filed Feb 16, 2017 20:40 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 2,033 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-006735 · form4.xml · nonDerivative · entry 2 FINNEY ELISHA W · CIK 0001217439 · Exec VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,070 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Read SEC document |
| February 15, 2017 Filed Feb 16, 2017 20:40 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 2,401 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-006735 · form4.xml · nonDerivative · entry 1 FINNEY ELISHA W · CIK 0001217439 · Exec VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,037 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Read SEC document |
| January 08, 2017 Filed Jan 9, 2017 18:01 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 362 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-002878 · doc4.xml · derivative · entry 2 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 362 shares Expires 2017-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. Read SEC document |
| January 08, 2017 Filed Jan 9, 2017 18:01 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 362 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-002878 · doc4.xml · nonDerivative · entry 1 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. Read SEC document |
| November 18, 2016 Filed Nov 21, 2016 17:06 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Tax withholdingCommon Stock | 1,432 | $88.25 | $126,374.00 |
DisclosureSEC source: 0001127602-16-067903 · form4.xml · nonDerivative · entry 2 FINNEY ELISHA W · CIK 0001217439 · Exec VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,636 F2 · shares: Represents shares withheld from vested PSUs for the payment of federal, state and payroll taxes due on settlement. F3 · balance_after: Amount of securities beneficially owned at end of reporting period reflect 128 shares purchased on October 28, 2016 under the Varian Medical Systems, Inc. Employee Stock Purchase Plan. Read SEC document |
| November 18, 2016 Filed Nov 21, 2016 17:06 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantCommon Stock | 2,745 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-067903 · form4.xml · nonDerivative · entry 1 FINNEY ELISHA W · CIK 0001217439 · Exec VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,068 F1 · shares: Represents shares issued upon settlement of performance-based unit award (PSUs) granted November 20, 2013. Read SEC document |
| October 03, 2016 Filed Oct 4, 2016 17:19 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 4,668 | $0.00 Strike: $68.84 | $0.00 |
DisclosureSEC source: 0001127602-16-064132 · form4.xml · derivative · entry 5 FINNEY ELISHA W · CIK 0001217439 · Exec VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,668 shares Expires 2019-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F4 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan, which complies with Rule 16b-3. The option vests as follows: one third on 11/09/2013, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| October 03, 2016 Filed Oct 4, 2016 17:19 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 1,358 | $99.21 | $134,727.99 |
DisclosureSEC source: 0001127602-16-064132 · form4.xml · nonDerivative · entry 3 FINNEY ELISHA W · CIK 0001217439 · Exec VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,195 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F3 · price: The 1,358 shares were sold in multiple transactions executed on the same day at prices ranging from $99.13 to $99.35. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| October 03, 2016 Filed Oct 4, 2016 17:19 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 3,310 | $98.73 | $326,809.21 |
DisclosureSEC source: 0001127602-16-064132 · form4.xml · nonDerivative · entry 2 FINNEY ELISHA W · CIK 0001217439 · Exec VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,553 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · price: The 3,310 shares were sold in multiple transactions executed on the same day at prices ranging from $98.28 to $99.03. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| October 03, 2016 Filed Oct 4, 2016 17:19 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 4,668 | $68.84 | $321,345.12 |
DisclosureSEC source: 0001127602-16-064132 · form4.xml · nonDerivative · entry 1 FINNEY ELISHA W · CIK 0001217439 · Exec VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,863 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| September 07, 2016 Filed Sep 8, 2016 19:04 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 9,000 | $0.00 Strike: $68.84 | $0.00 |
DisclosureSEC source: 0001127602-16-062287 · form4.xml · derivative · entry 4 FINNEY ELISHA W · CIK 0001217439 · Exec VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,668 Underlying: Common Stock · 9,000 shares Expires 2019-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan, which complies with Rule 16b-3. The option vests as follows: one third on 11/09/2013, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| September 07, 2016 Filed Sep 8, 2016 19:04 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 9,000 | $96.95 | $872,550.00 |
DisclosureSEC source: 0001127602-16-062287 · form4.xml · nonDerivative · entry 2 FINNEY ELISHA W · CIK 0001217439 · Exec VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,195 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| September 07, 2016 Filed Sep 8, 2016 19:04 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 9,000 | $68.84 | $619,560.00 |
DisclosureSEC source: 0001127602-16-062287 · form4.xml · nonDerivative · entry 1 FINNEY ELISHA W · CIK 0001217439 · Exec VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,195 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.